Evidence map›Paper›PMID 16273112›Full record

ReviewBone marrow transplantation2006

Transfer of the hematopoietic stem cell transplant patient to the intensive care unit: does it really matter?

N Naeem, M D Reed, R J Creger, S J Youngner, H M Lazarus

Abstract readReview
PubMed Publisher
In one paragraph

Review in Bone marrow transplantation, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Pediatric Hematopoietic Cell Transplant Patients Who Survive Critical Illness Frequently Have Significant but Recoverable Decline in Functional Status.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2018
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

N NaeemDepartment of Medicine, Division of Hematology-Oncology, Cleveland, OH, USA.
M D Reed
R J Creger
S J Youngner
H M Lazarus
Cleveland Clinic · USUniversity Hospitals of Cleveland · US

Funding

Pediatric Pharmacology Research UnitU10HD031323 · NICHD · CASE WESTERN RESERVE UNIVERSITY · PI BLUMER, JEFFREY L. · 2004 to 2009
$2.2M
PEDIATRIC PHARMOCOLOGY RESEARCH UNITU01HD031323 · NICHD · CASE WESTERN RESERVE UNIVERSITY · PI BLUMER, JEFFREY L · 1994 to 2003
$2.0M
NICHD NIH HHS HD31323-12
6 · The paper itself

Abstract

We critically reviewed published English language literature and concluded that from 1998 onward the survival of hematopoietic stem cell transplant (SCT) patients who experienced intensive care unit (ICU) transfer has improved. The factors associated with increased mortality during ICU stay included increased patient age, allogeneic transplant, intubation/mechanical ventilation, multiorgan system failure (MOSF), presumed/documented infection, graft-versus-host disease, and higher APACHE and O-PRISM score at ICU transfer. This encouraging outcome trend reflects evolving advances such as use of recombinant hematopoietic growth factors, use of mobilized blood cells rather than marrow, protective strategies for acute lung injury and early goal-directed therapy for sepsis syndrome. Patient selection bias (which patients were transferred and which were not sent to an ICU) also plays a role in ICU survival rates. New strategies to improve upon SCT patient outcome include use of a scoring system to predict mortality, better therapies for MOSF and integration of ICU components and multispecialist involvement earlier in the clinical course to prevent severe complications such as respiratory failure. SCT recipients comprise a heterogeneous group; to further advance this field, prospective multicenter trials involving larger populations from many centers are needed to reduce the biases of retrospective and single-center reports.

Indexed as

Hematopoietic Stem Cell TransplantationIntensive Care UnitsAge FactorsCritical CareDisease-Free SurvivalHumansMulticenter Studies as TopicResearch DesignRetrospective StudiesRisk FactorsSelection BiasTransplantation, AutologousTransplantation, HomologousTreatment Outcome

Identifiers

PMID16273112
OpenAlexW1968020058

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.